MiNK Therapeutics, Inc.
INKT$11M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaNEW YORK23 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 2027
Market Overview
Stock performance and key metrics
INKT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
agenT-797 | Phase 2 | Pneumonia | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply